CervoMed (CRVO) Equity Average (2022 - 2025)
Historic Equity Average for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $29.7 million.
- CervoMed's Equity Average fell 3782.19% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year decrease of 3782.19%. This contributed to the annual value of $23.3 million for FY2024, which is 27978.46% up from last year.
- According to the latest figures from Q3 2025, CervoMed's Equity Average is $29.7 million, which was down 3782.19% from $34.0 million recorded in Q2 2025.
- CervoMed's Equity Average's 5-year high stood at $47.8 million during Q3 2024, with a 5-year trough of -$34.4 million in Q2 2023.
- Moreover, its 4-year median value for Equity Average was $27.7 million (2024), whereas its average is $15.9 million.
- In the last 5 years, CervoMed's Equity Average plummeted by 22020.04% in 2023 and then soared by 48079.08% in 2025.
- Over the past 4 years, CervoMed's Equity Average (Quarter) stood at -$4.6 million in 2022, then soared by 283.59% to $8.5 million in 2023, then surged by 400.5% to $42.4 million in 2024, then decreased by 29.93% to $29.7 million in 2025.
- Its last three reported values are $29.7 million in Q3 2025, $34.0 million for Q2 2025, and $36.9 million during Q1 2025.